NYSE:AMRX
Amneal Pharmaceuticals, Inc. Stock News
$6.45
+0.0100 (+0.155%)
At Close: May 24, 2024
Amneal Pharmaceuticals (AMRX) Gains As Market Dips: What You Should Know
09:45pm, Thursday, 23'rd Jul 2020
In the latest trading session, Amneal Pharmaceuticals (AMRX) closed at $4.46, marking a +0.45% move from the previous day.
Can Amneal (AMRX) Keep the Earnings Surprise Streak Alive?
04:10pm, Wednesday, 22'nd Jul 2020
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Amneal Pharmaceuticals (AMRX) Gains But Lags Market: What You Should Know
09:45pm, Friday, 17'th Jul 2020
Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.86, moving +0.21% from the previous trading session.
Could The Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Ownership Structure Tell Us Something Useful?
11:29am, Thursday, 16'th Jul 2020
The big shareholder groups in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) have power over the company. Insiders often own...
DBV Technologies' Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
07:49pm, Monday, 13'th Jul 2020
DBVT reports positive extension study data. Amneal receives FDA approval for Generic Fluphenazine Hydrochloride.
Company News for Jul 13, 2020
01:44pm, Monday, 13'th Jul 2020
Companies in the news are: BNGO, AMRX, ALT, EXPR
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
12:30pm, Monday, 13'th Jul 2020
FLORHAM PARK, N.J., July 13, 2020 -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing.
Lannett to cut jobs following FDA approval of competing generic drug
11:34am, Monday, 13'th Jul 2020
Shares of Lannett Company Inc. undefined gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that...
Lannett to cut jobs following FDA approval of competing generic drug
11:34am, Monday, 13'th Jul 2020
Shares of Lannett Company Inc. gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that its generic fluphenazine product will face competitio
Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA
12:00pm, Friday, 10'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (
Amneal Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
11:18am, Thursday, 09'th Jul 2020
Amneal Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.
Amneal Pharmaceuticals (AMRX) Stock Sinks As Market Gains: What You Should Know
09:50pm, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals (AMRX) closed the most recent trading day at $4.51, moving -0.66% from the previous trading session.
Amneal to Report Second Quarter 2020 Results on August 6, 2020
12:00pm, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to market open. The Company will ho
Amneal to Report Second Quarter 2020 Results on August 6, 2020
12:00am, Wednesday, 08'th Jul 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August
AMRX vs. COLL: Which Stock Should Value Investors Buy Now?
03:40pm, Tuesday, 07'th Jul 2020
AMRX vs. COLL: Which Stock Is the Better Value Option?
